LNP023 (iptacopan)

iptacopan · Novartis

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LNP023 (iptacopan), covering 2024-07-05 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V [Phase 2]